|
|
|
Insider
Information: |
Angermayer Christian |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
251,881 |
|
Indirect Shares
|
34,560,657 |
|
|
Direct
Value |
$1,015,080 |
|
|
Indirect Value
|
$40,671,191 |
|
|
Total
Shares |
34,812,538 |
|
|
Total
Value |
$41,686,271 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Atai Life Sciences B.v. |
ATAI |
10% Owner |
|
0 |
2023-03-29 |
33,885,999 |
Premium* |
|
Alto Neuroscience, Inc. |
ANRO |
|
2024-02-06 |
251,881 |
2024-02-06 |
674,658 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ATAI |
Atai Life Sciences B.v. |
Director |
|
2021-06-22 |
4 |
B |
$15.00 |
$10,500,000 |
I/I |
700,000 |
20,185,200 |
2.25 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-14 |
4 |
B |
$5.19 |
$25,779 |
I/I |
4,967 |
1,358,883 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-19 |
4 |
B |
$5.13 |
$334,739 |
I/I |
65,315 |
1,478,520 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-18 |
4 |
B |
$5.11 |
$277,656 |
I/I |
54,322 |
1,413,205 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-20 |
4 |
B |
$5.09 |
$344,513 |
I/I |
67,703 |
1,546,223 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-21 |
4 |
B |
$4.95 |
$340,040 |
I/I |
68,688 |
1,614,911 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-12 |
4 |
B |
$4.88 |
$269,560 |
I/I |
55,197 |
1,353,916 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-11 |
4 |
B |
$4.83 |
$260,554 |
I/I |
53,926 |
1,298,719 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-22 |
4 |
B |
$4.83 |
$254,962 |
I/I |
52,820 |
1,667,731 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-08 |
4 |
B |
$4.81 |
$277,640 |
I/I |
57,689 |
1,244,793 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-25 |
4 |
B |
$4.78 |
$42,843 |
I/I |
8,961 |
1,676,692 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-26 |
4 |
B |
$4.69 |
$216,628 |
I/I |
46,207 |
1,722,899 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-27 |
4 |
B |
$4.64 |
$91,939 |
I/I |
19,803 |
1,742,702 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-29 |
4 |
B |
$4.47 |
$97,801 |
I/I |
21,900 |
1,799,302 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2022-04-28 |
4 |
B |
$4.46 |
$154,689 |
I/I |
34,700 |
1,777,402 |
1.5 |
- |
|
ATAI |
Atai Life Sciences B.v. |
10% Owner |
|
2023-03-29 |
4 |
B |
$1.32 |
$1,600,443 |
I/I |
1,214,297 |
32,086,697 |
1.5 |
% |
|
ANRO |
Alto Neuroscience, Inc. |
See Remarks |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
251,881 |
251,881 |
0 |
- |
|
ANRO |
Alto Neuroscience, Inc. |
See Remarks |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
I/I |
674,658 |
674,658 |
0 |
- |
|
ATAI |
Atai Life Sciences B.v. |
Director |
|
2021-06-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
20,672,304 |
|
- |
|
ATAI |
Atai Life Sciences B.v. |
Director |
|
2021-06-17 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
27,805,200 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|